Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina

Table 3 Sociodemographic and Clinical Characteristics of HIV-positive Individuals by Early or Late Start of Treatment

	Treatment Initiation at Baseline
Variable	Early Access (CD4 > 200 cells/mcL)(n = 181)	Late Access (CD4 ≤ 200 cells/mcL)(n = 397)	P value
Sex*
Male	118 (66)	277 (70)	.33
Female	62 (34)	119 (30)
Age (years)^†	35 (30–42)	36 (31–43)	.20
MSM (n = 178)*	60 (33)	118 (30)	.44
IDU (n = 79)*	18 (10)	61 (15)	.09
Heterosexual transmission (n = 300)*	95 (52)	205 (52)	1.00
Prior AIDS-defining illness*
No	155 (86)	233 (59)	<.0001
Yes	26 (14)	164 (41)
HIV RNA (copies/mL)^†	60,559 (16,323–181,700)	133,824 (48,541–383,000)	<.0001

Note: Documented results of CD4 cell count within 1 year prior to starting treatment were missing for 69 patients, and these patients were eliminated from analysis.
*Number (percentage)
^†Median (interquartile range)
IDU = injection drug use; mcL = microliter; MSM = men who have sex with men